1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide

C38H42N8O4 — CID 176758146

IUPAC1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide
SMILESC=C(CN1CC2CC(C1)O2)C(=O)N(C)Cc1cccc([C@@H]2c3cnn(-c4ccccc4)c3N(CC)C(=O)[C@H]2NC(=O)c2ccn(C3CC3)n2)c1
InChIInChI=1S/C38H42N8O4/c1-4-44-36-31(19-39-46(36)28-11-6-5-7-12-28)33(34(38(44)49)40-35(47)32-15-16-45(41-32)27-13-14-27)26-10-8-9-25(17-26)21-42(3)37(48)24(2)20-43-22-29-18-30(23-43)50-29/h5-12,15-17,19,27,29-30,33-34H,2,4,13-14,18,20-23H2,1,3H3,(H,40,47)/t29?,30?,33-,34+/m1/s1
InChIKeyCIYMORZWYDCXQO-FLYOXLRNSA-N
MW674.81 g/mol
LogP3.69
Rot. Bonds11

About 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide

1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide (PubChem CID 176758146) has the molecular formula C38H42N8O4 and a molecular weight of 674.81 g/mol. Its IUPAC name is 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide.

Molecular Properties

Compound Name1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide
PubChem CID176758146
Molecular FormulaC38H42N8O4
Molecular Weight674.81 g/mol
Exact Mass674.33
IUPAC Name1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide
SMILESC=C(CN1CC2CC(C1)O2)C(=O)N(C)Cc1cccc([C@@H]2c3cnn(-c4ccccc4)c3N(CC)C(=O)[C@H]2NC(=O)c2ccn(C3CC3)n2)c1
InChIInChI=1S/C38H42N8O4/c1-4-44-36-31(19-39-46(36)28-11-6-5-7-12-28)33(34(38(44)49)40-35(47)32-15-16-45(41-32)27-13-14-27)26-10-8-9-25(17-26)21-42(3)37(48)24(2)20-43-22-29-18-30(23-43)50-29/h5-12,15-17,19,27,29-30,33-34H,2,4,13-14,18,20-23H2,1,3H3,(H,40,47)/t29?,30?,33-,34+/m1/s1
InChIKeyCIYMORZWYDCXQO-FLYOXLRNSA-N
XLogP3.69
TPSA117.83 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds11
Heavy Atoms50
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500674.81
LogP ≤ 53.69
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide?
The IUPAC name of 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide (CID 176758146) is 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide.
What is the SMILES notation for 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide?
The canonical SMILES for 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide is C=C(CN1CC2CC(C1)O2)C(=O)N(C)Cc1cccc([C@@H]2c3cnn(-c4ccccc4)c3N(CC)C(=O)[C@H]2NC(=O)c2ccn(C3CC3)n2)c1.
What is the InChIKey of 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide?
The InChIKey is CIYMORZWYDCXQO-FLYOXLRNSA-N. The full InChI is InChI=1S/C38H42N8O4/c1-4-44-36-31(19-39-46(36)28-11-6-5-7-12-28)33(34(38(44)49)40-35(47)32-15-16-45(41-32)27-13-14-27)26-10-8-9-25(17-26)21-42(3)37(48)24(2)20-43-22-29-18-30(23-43)50-29/h5-12,15-17,19,27,29-30,33-34H,2,4,13-14,18,20-23H2,1,3H3,(H,40,47)/t29?,30?,33-,34+/m1/s1.
What are the key properties of 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide?
1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide has a molecular weight of 674.81 g/mol, XLogP of 3.69, 11 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 1-cyclopropyl-N-[(4R,5S)-7-ethyl-4-[3-[[methyl-[2-(6-oxa-3-azabicyclo[3.1.1]heptan-3-ylmethyl)prop-2-enoyl]amino]methyl]phenyl]-6-oxo-1-phenyl-4,5-dihydropyrazolo[5,4-b]pyridin-5-yl]pyrazole-3-carboxamide is sourced from PubChem (CID 176758146), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).